The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience
The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-ter...
Gespeichert in:
| Veröffentlicht in: | Endocrine-related cancer 2020-09, Vol.27 (9), p.R307-R327 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | R327 |
|---|---|
| container_issue | 9 |
| container_start_page | R307 |
| container_title | Endocrine-related cancer |
| container_volume | 27 |
| creator | Chan, Jack Junjie Sim, Yirong Ow, Samuel Guan Wei Lim, Joline Si Jing Kusumawidjaja, Grace Zhuang, Qingyuan Wong, Ru Xin Wong, Fuh Yong Tan, Veronique Kiak Mien Tan, Tira Jing Ying |
| description | The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-term oncological outcomes from the treatment decisions undertaken during this extraordinary period, and diverted healthcare resources to support a coordinated whole-of-society outbreak response. In this review, we chronicle the repercussions of the COVID-19 outbreak on breast cancer management in Singapore and describe our approach to triaging and prioritising care of breast tumours. We further propose adaptations to established clinical processes and practices across the different specialties involved in breast oncology, with references to the relevant evidence base or expert consensus guidelines. These recommendations have been developed within the unique context of Singapore’s public healthcare sector. They can serve as a resource to guide breast cancer management for future contingencies in this city-state, while certain elements therein may be extrapolatable to other medical systems during this global public health emergency. |
| doi_str_mv | 10.1530/ERC-20-0157 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2414409424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2447010238</sourcerecordid><originalsourceid>FETCH-LOGICAL-b396t-bdd7558d9b746427b2daace7ea322e0707561fcea5d23950056503d7731d45703</originalsourceid><addsrcrecordid>eNp9kE1r3DAQQEVJySabnHovglwKwenoy7J7K5vNBwQW2k2PNbI0ThXWliN5of330bJJDznkNAPzeAyPkE8MLpgS8HX5Y1FwKIAp_YEcManroqw4O8i7UKwAqKoZOU7pEQDKSqlDMhNcSVnp-oj8Xv9B6vvR2ImGji5Wv24vC1bTMFAzOBrRhr7HwZnJhyHRLkTaRjRpotYMFmMeEb_RKVt--uHBjCEixb8jRo_5fkI-dmaT8PRlzsn91XK9uCnuVte3i-93RSvqcipa57RSlatbLUvJdcudMRY1GsE5ggatStZZNMpxUSsAVSoQTmvBnFQaxJx82XvHGJ62mKam98niZmMGDNvUcMmkhFpymdGzN-hj2MYhf5cpqYEBF1WmzveUjSGliF0zRt-b-K9h0OyyNzl7w6HZZc_05xfntu3R_WdfO2eA7YHWh2Rzmsl33pp3pc_ijIqK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2447010238</pqid></control><display><type>article</type><title>The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Society for Endocrinology Journals</source><creator>Chan, Jack Junjie ; Sim, Yirong ; Ow, Samuel Guan Wei ; Lim, Joline Si Jing ; Kusumawidjaja, Grace ; Zhuang, Qingyuan ; Wong, Ru Xin ; Wong, Fuh Yong ; Tan, Veronique Kiak Mien ; Tan, Tira Jing Ying</creator><creatorcontrib>Chan, Jack Junjie ; Sim, Yirong ; Ow, Samuel Guan Wei ; Lim, Joline Si Jing ; Kusumawidjaja, Grace ; Zhuang, Qingyuan ; Wong, Ru Xin ; Wong, Fuh Yong ; Tan, Veronique Kiak Mien ; Tan, Tira Jing Ying</creatorcontrib><description>The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-term oncological outcomes from the treatment decisions undertaken during this extraordinary period, and diverted healthcare resources to support a coordinated whole-of-society outbreak response. In this review, we chronicle the repercussions of the COVID-19 outbreak on breast cancer management in Singapore and describe our approach to triaging and prioritising care of breast tumours. We further propose adaptations to established clinical processes and practices across the different specialties involved in breast oncology, with references to the relevant evidence base or expert consensus guidelines. These recommendations have been developed within the unique context of Singapore’s public healthcare sector. They can serve as a resource to guide breast cancer management for future contingencies in this city-state, while certain elements therein may be extrapolatable to other medical systems during this global public health emergency.</description><identifier>ISSN: 1351-0088</identifier><identifier>EISSN: 1479-6821</identifier><identifier>DOI: 10.1530/ERC-20-0157</identifier><identifier>PMID: 32544879</identifier><language>eng</language><publisher>England: Bioscientifica Ltd</publisher><subject>Adaptation ; Betacoronavirus ; Breast cancer ; Breast Neoplasms - therapy ; Clinical Trials as Topic ; Coronavirus Infections - epidemiology ; Coronaviruses ; COVID-19 ; Female ; Humans ; Malignancy ; Oncology ; Pandemics ; Patients ; Pneumonia, Viral - epidemiology ; Practice Guidelines as Topic ; Public health ; Review ; SARS-CoV-2 ; Singapore - epidemiology ; Tumors</subject><ispartof>Endocrine-related cancer, 2020-09, Vol.27 (9), p.R307-R327</ispartof><rights>2020 Society for Endocrinology</rights><rights>Copyright Society for Endocrinology & BioScientifica Ltd. Sep 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b396t-bdd7558d9b746427b2daace7ea322e0707561fcea5d23950056503d7731d45703</citedby><orcidid>0000-0002-7214-8368</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3950,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32544879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Jack Junjie</creatorcontrib><creatorcontrib>Sim, Yirong</creatorcontrib><creatorcontrib>Ow, Samuel Guan Wei</creatorcontrib><creatorcontrib>Lim, Joline Si Jing</creatorcontrib><creatorcontrib>Kusumawidjaja, Grace</creatorcontrib><creatorcontrib>Zhuang, Qingyuan</creatorcontrib><creatorcontrib>Wong, Ru Xin</creatorcontrib><creatorcontrib>Wong, Fuh Yong</creatorcontrib><creatorcontrib>Tan, Veronique Kiak Mien</creatorcontrib><creatorcontrib>Tan, Tira Jing Ying</creatorcontrib><title>The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience</title><title>Endocrine-related cancer</title><addtitle>Endocr Relat Cancer</addtitle><description>The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-term oncological outcomes from the treatment decisions undertaken during this extraordinary period, and diverted healthcare resources to support a coordinated whole-of-society outbreak response. In this review, we chronicle the repercussions of the COVID-19 outbreak on breast cancer management in Singapore and describe our approach to triaging and prioritising care of breast tumours. We further propose adaptations to established clinical processes and practices across the different specialties involved in breast oncology, with references to the relevant evidence base or expert consensus guidelines. These recommendations have been developed within the unique context of Singapore’s public healthcare sector. They can serve as a resource to guide breast cancer management for future contingencies in this city-state, while certain elements therein may be extrapolatable to other medical systems during this global public health emergency.</description><subject>Adaptation</subject><subject>Betacoronavirus</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - therapy</subject><subject>Clinical Trials as Topic</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Female</subject><subject>Humans</subject><subject>Malignancy</subject><subject>Oncology</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Practice Guidelines as Topic</subject><subject>Public health</subject><subject>Review</subject><subject>SARS-CoV-2</subject><subject>Singapore - epidemiology</subject><subject>Tumors</subject><issn>1351-0088</issn><issn>1479-6821</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQQEVJySabnHovglwKwenoy7J7K5vNBwQW2k2PNbI0ThXWliN5of330bJJDznkNAPzeAyPkE8MLpgS8HX5Y1FwKIAp_YEcManroqw4O8i7UKwAqKoZOU7pEQDKSqlDMhNcSVnp-oj8Xv9B6vvR2ImGji5Wv24vC1bTMFAzOBrRhr7HwZnJhyHRLkTaRjRpotYMFmMeEb_RKVt--uHBjCEixb8jRo_5fkI-dmaT8PRlzsn91XK9uCnuVte3i-93RSvqcipa57RSlatbLUvJdcudMRY1GsE5ggatStZZNMpxUSsAVSoQTmvBnFQaxJx82XvHGJ62mKam98niZmMGDNvUcMmkhFpymdGzN-hj2MYhf5cpqYEBF1WmzveUjSGliF0zRt-b-K9h0OyyNzl7w6HZZc_05xfntu3R_WdfO2eA7YHWh2Rzmsl33pp3pc_ijIqK</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Chan, Jack Junjie</creator><creator>Sim, Yirong</creator><creator>Ow, Samuel Guan Wei</creator><creator>Lim, Joline Si Jing</creator><creator>Kusumawidjaja, Grace</creator><creator>Zhuang, Qingyuan</creator><creator>Wong, Ru Xin</creator><creator>Wong, Fuh Yong</creator><creator>Tan, Veronique Kiak Mien</creator><creator>Tan, Tira Jing Ying</creator><general>Bioscientifica Ltd</general><general>Society for Endocrinology & BioScientifica Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7214-8368</orcidid></search><sort><creationdate>20200901</creationdate><title>The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience</title><author>Chan, Jack Junjie ; Sim, Yirong ; Ow, Samuel Guan Wei ; Lim, Joline Si Jing ; Kusumawidjaja, Grace ; Zhuang, Qingyuan ; Wong, Ru Xin ; Wong, Fuh Yong ; Tan, Veronique Kiak Mien ; Tan, Tira Jing Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b396t-bdd7558d9b746427b2daace7ea322e0707561fcea5d23950056503d7731d45703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adaptation</topic><topic>Betacoronavirus</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - therapy</topic><topic>Clinical Trials as Topic</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Female</topic><topic>Humans</topic><topic>Malignancy</topic><topic>Oncology</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Practice Guidelines as Topic</topic><topic>Public health</topic><topic>Review</topic><topic>SARS-CoV-2</topic><topic>Singapore - epidemiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Jack Junjie</creatorcontrib><creatorcontrib>Sim, Yirong</creatorcontrib><creatorcontrib>Ow, Samuel Guan Wei</creatorcontrib><creatorcontrib>Lim, Joline Si Jing</creatorcontrib><creatorcontrib>Kusumawidjaja, Grace</creatorcontrib><creatorcontrib>Zhuang, Qingyuan</creatorcontrib><creatorcontrib>Wong, Ru Xin</creatorcontrib><creatorcontrib>Wong, Fuh Yong</creatorcontrib><creatorcontrib>Tan, Veronique Kiak Mien</creatorcontrib><creatorcontrib>Tan, Tira Jing Ying</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine-related cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Jack Junjie</au><au>Sim, Yirong</au><au>Ow, Samuel Guan Wei</au><au>Lim, Joline Si Jing</au><au>Kusumawidjaja, Grace</au><au>Zhuang, Qingyuan</au><au>Wong, Ru Xin</au><au>Wong, Fuh Yong</au><au>Tan, Veronique Kiak Mien</au><au>Tan, Tira Jing Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience</atitle><jtitle>Endocrine-related cancer</jtitle><addtitle>Endocr Relat Cancer</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>27</volume><issue>9</issue><spage>R307</spage><epage>R327</epage><pages>R307-R327</pages><issn>1351-0088</issn><eissn>1479-6821</eissn><abstract>The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-term oncological outcomes from the treatment decisions undertaken during this extraordinary period, and diverted healthcare resources to support a coordinated whole-of-society outbreak response. In this review, we chronicle the repercussions of the COVID-19 outbreak on breast cancer management in Singapore and describe our approach to triaging and prioritising care of breast tumours. We further propose adaptations to established clinical processes and practices across the different specialties involved in breast oncology, with references to the relevant evidence base or expert consensus guidelines. These recommendations have been developed within the unique context of Singapore’s public healthcare sector. They can serve as a resource to guide breast cancer management for future contingencies in this city-state, while certain elements therein may be extrapolatable to other medical systems during this global public health emergency.</abstract><cop>England</cop><pub>Bioscientifica Ltd</pub><pmid>32544879</pmid><doi>10.1530/ERC-20-0157</doi><orcidid>https://orcid.org/0000-0002-7214-8368</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1351-0088 |
| ispartof | Endocrine-related cancer, 2020-09, Vol.27 (9), p.R307-R327 |
| issn | 1351-0088 1479-6821 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2414409424 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Society for Endocrinology Journals |
| subjects | Adaptation Betacoronavirus Breast cancer Breast Neoplasms - therapy Clinical Trials as Topic Coronavirus Infections - epidemiology Coronaviruses COVID-19 Female Humans Malignancy Oncology Pandemics Patients Pneumonia, Viral - epidemiology Practice Guidelines as Topic Public health Review SARS-CoV-2 Singapore - epidemiology Tumors |
| title | The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A48%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20COVID-19%20on%20and%20recommendations%20for%20breast%20cancer%20care:%20the%20Singapore%20experience&rft.jtitle=Endocrine-related%20cancer&rft.au=Chan,%20Jack%20Junjie&rft.date=2020-09-01&rft.volume=27&rft.issue=9&rft.spage=R307&rft.epage=R327&rft.pages=R307-R327&rft.issn=1351-0088&rft.eissn=1479-6821&rft_id=info:doi/10.1530/ERC-20-0157&rft_dat=%3Cproquest_cross%3E2447010238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2447010238&rft_id=info:pmid/32544879&rfr_iscdi=true |